Fourth, we were not able to stratify our sample regarding Aβ status, which leaves it open whether AD-related or non–AD-related tau pathology (PART/SNAP) causes the observed effects which we aim to achieve with a bigger dataset in the future. Here, MAPT is linked to Alzheimer disease.